Related Experiment Videos
CSF proteome: a protein repository for potential biomarker identification
Martin J Romeo1, Virginia Espina, Mark Lowenthal
1Laboratory of Pathology, Center for Cancer Research, National Cancer Institute, National Institutes of Health, 9000 Rockville Pike, Bethesda, MD 20892, USA. romeoma@mail.nih.gov
Expert Review of Proteomics
|June 22, 2005
Summary
Cerebrospinal fluid proteomic analysis offers unique insights into disease beyond neurological disorders. Sensitive techniques are crucial for detecting less abundant proteins and identifying novel biomarkers for diagnosis and prognosis.
Area of Science:
- Proteomics
- Biomarker Discovery
- Clinical Diagnostics
Background:
- Body fluids beyond serum and tissues, including cerebrospinal fluid (CSF), possess unique proteomes.
- CSF contains peptides, proteolytic fragments, and antibodies that cross the blood-brain barrier, offering pathological information.
- CSF proteomes are valuable for disease diagnosis and prognosis, extending beyond neurological conditions.
Purpose of the Study:
- To review promising areas of cerebrospinal fluid proteomic research.
- To highlight the clinical applications of CSF proteomic analysis.
- To emphasize the potential of CSF as a source of non-neurologic disease biomarkers.
Main Methods:
- Proteomic technologies including immunoblotting, isoelectric focusing, 2D gel electrophoresis, and mass spectrometry are employed.
- Sensitive analytical techniques are necessary due to lower protein abundance in CSF compared to serum.
- Analysis focuses on deciphering the unique proteome of cerebrospinal fluid.
Main Results:
- Cerebrospinal fluid analysis reveals unique proteomes with diagnostic and prognostic potential.
- Proteins, peptides, and antibodies in CSF provide insights into various pathological conditions.
- The review identifies promising research avenues in CSF proteomics.
Conclusions:
- Cerebrospinal fluid proteomic analysis is a valuable tool for disease diagnosis and prognosis.
- CSF biomarkers can indicate pathologies beyond the central nervous system.
- Advancements in sensitive proteomic techniques are key to unlocking CSF's full potential.